Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:VAU
ASX:VAUMetals and Mining

ASX Value Stock Picks Including Navigator Global Investments For Possible Capital Growth

As the Australian market faces a dip amid concerns over supply disruptions from the Iran conflict and potential threats to vital shipping routes, investors are cautiously navigating these turbulent waters. In such uncertain times, identifying undervalued stocks that offer potential for capital growth can be a strategic move, especially when focusing on companies like Navigator Global Investments that may present opportunities despite broader market challenges.
ASX:WDS
ASX:WDSOil and Gas

Is It Too Late To Consider Woodside Energy Group (ASX:WDS) After Its Strong Share Price Run?

Wondering whether Woodside Energy Group is still good value at around A$35.22, or if the recent run has already priced in the upside. The share price sits at A$35.22, with returns of 1.2% over 7 days, 24.4% over 30 days, 48.9% year to date, 61.5% over 1 year, 25.2% over 3 years and 113.7% over 5 years, which naturally raises questions about what is already reflected in the price. Recent coverage has focused on Woodside as a major ASX energy name, with attention on how its scale and project...
NYSE:MNTN
NYSE:MNTNMedia

Exploring High Growth Tech Stocks in the US Market

Over the last 7 days, the United States market has dropped 1.9%, yet it remains up by 15% over the past year with earnings forecasted to grow by 15% annually, indicating a resilient and optimistic outlook for investors. In this context, identifying high growth tech stocks involves assessing companies that not only capitalize on technological advancements but also demonstrate strong potential for sustained revenue and earnings growth in line with or exceeding these market trends.
NasdaqGS:SMCI
NasdaqGS:SMCITech

3 Prominent Stocks Estimated To Be Trading At Discounts Up To 45.1%

Over the last 7 days, the United States market has experienced a 1.9% decline; however, it remains up by 15% over the past year with earnings projected to grow by 15% annually. In this context, identifying stocks that are trading at significant discounts can present valuable opportunities for investors seeking to capitalize on potential growth while navigating current market fluctuations.
SEHK:9985
SEHK:9985Food

A Look At WEILONG Delicious Global Holdings (SEHK:9985) Valuation After Strong Full Year 2025 Results

WEILONG Delicious Global Holdings (SEHK:9985) has drawn fresh attention after reporting full year 2025 results, with sales of CN¥7,223.76 million and net income of CN¥1,425.2 million compared to the prior year. See our latest analysis for WEILONG Delicious Global Holdings. The latest full year earnings arrived after a weak run for shareholders, with the 1 year total shareholder return at a 34.02% loss and the 30 day share price return at a 17.34% loss, while the 3 year total shareholder...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

March 2026's Leading Growth Companies With Insider Confidence

Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually in the coming years. In this environment, identifying growth companies with high insider ownership can be particularly appealing as it suggests management's confidence in their long-term potential amidst these fluctuating market conditions.
ASX:RGN
ASX:RGNRetail REITs

A Look At Region Group’s Valuation As It Completes And Extends Its Share Buyback Program

Region Group (ASX:RGN) has completed its previously announced on market share buyback, repurchasing 14,100,000 shares for A$33.1 million, and extended the program’s duration through April 2, 2027, underscoring ongoing capital management efforts. See our latest analysis for Region Group. At a latest share price of A$2.23, Region Group’s recent 1-day and 7-day share price returns in positive territory contrast with weaker 90 day and year to date share price returns. The 1 year total shareholder...
NasdaqGS:CVGW
NasdaqGS:CVGWFood

Undiscovered Gems in the US Market to Explore This March 2026

Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 15% over the past year with earnings projected to grow annually by the same percentage. In this dynamic environment, identifying stocks that are not only resilient but also positioned for growth can be crucial for investors seeking opportunities beyond well-trodden paths.
NasdaqGS:WABC
NasdaqGS:WABCBanks

Top Dividend Stocks To Consider In March 2026

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with annual earnings growth forecasted at 15%. In this dynamic environment, identifying dividend stocks that offer reliable income and potential for capital appreciation can be an effective strategy for investors seeking stability and growth.
TSE:6702
TSE:6702IT

Is It Time To Reassess Fujitsu (TSE:6702) After Its Recent Share Price Pullback?

If you are wondering whether Fujitsu's current share price reflects its true worth, it helps to step back and look at both recent returns and what the underlying valuation signals are saying. The stock last closed at ¥3,112, with returns of 5.9% over 1 year, 75.0% over 3 years, and 100.0% over 5 years. The year-to-date move of 27.8% and recent 7-day and 30-day declines of 4.8% and 13.3% highlight that sentiment can shift quickly. Recent headlines around Fujitsu have focused on its position...
NYSE:CRBG
NYSE:CRBGDiversified Financial

A Look At Corebridge Financial (CRBG) Valuation After Recent Share Price Weakness

Corebridge Financial stock: recent performance snapshot Corebridge Financial (CRBG) has drawn attention after recent share price weakness, with the stock showing negative returns over the past month, past 3 months and year to date, prompting investors to reassess its risk and return trade off. See our latest analysis for Corebridge Financial. At a share price of US$22.30, Corebridge Financial has seen momentum fade recently, with a 30 day share price return of 13.70% decline and a 1 year...
OM:GETI B
OM:GETI BMedical Equipment

Is It Time To Reassess Getinge (OM:GETI B) After Its Recent Share Price Weakness

If you are wondering whether Getinge's share price matches the underlying value of the business, the next sections will walk through what the numbers are currently saying about that gap. Over recent periods the stock has been mixed, with a 1.3% return over 7 days, a 9.1% decline over 30 days, a 15.2% decline year to date, and a 12.3% decline over the past year. These moves come as investors continue to reassess medical equipment makers like Getinge, with sentiment often shifting quickly when...
SEHK:3696
SEHK:3696Life Sciences

Insilico Medicine Cayman TopCo FY 2025 Loss Deepens To US$352.3 Million Challenging Bullish Narratives

InSilico Medicine Cayman TopCo (SEHK:3696) has opened FY 2025 with first half revenue of US$27.5 million and a basic EPS loss of US$0.25, while trailing twelve month figures show revenue of US$56.2 million alongside a net loss of US$352.3 million and EPS of US$4.48 in the red. Over the recent reported periods, the company has seen revenue shift from US$59.7 million in the first half of FY 2024 to US$26.1 million in the second half and then to US$27.5 million in the first half of FY 2025. Net...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

Is Atlanta Braves Holdings (BATR.K) Pricing In Too Much Future Growth After Recent Pullback

Wondering if Atlanta Braves Holdings at around US$41.53 is offering good value or just a fan premium? This breakdown is designed to help you see what the current price really represents. The stock has seen a 1% decline over the last 7 days and a 5% decline over the last 30 days, while still showing returns of 4.2% year to date, 3.8% over 1 year, 23.2% over 3 years and 43.2% over 5 years. Recent coverage has focused on the company as a way to gain exposure to a well known sports franchise...
NYSE:CWAN
NYSE:CWANSoftware

Is Clearwater Analytics Holdings (CWAN) Fairly Priced After Recent 3-Year 48.6% Share Price Gain

Wondering if Clearwater Analytics Holdings at around US$23.49 is offering good value right now, or if the price already reflects most of the upside you care about. The stock has been relatively steady in the near term, with a 0.9% return over the last 7 days and 0.4% over the last 30 days, while year to date it shows a 2.6% decline and the 1 year return sits at a 12.4% decline, compared with a 48.6% gain over 3 years. Recent coverage has focused on Clearwater Analytics Holdings as a listed...
NYSE:JBS
NYSE:JBSFood

Assessing JBS (NYSE:JBS) Valuation After Recent Share Price Momentum And Earnings Stability

With no single headline event driving attention today, JBS (NYSE:JBS) is drawing interest as investors look at its recent share moves and its sizeable global meat processing footprint across beef, pork, poultry, and prepared foods. See our latest analysis for JBS. JBS’s recent 7 day share price return of 13.01% and 90 day share price return of 17.53%, with the stock now at $17.03, suggest momentum has picked up after a quieter 30 day share price return of 0.83%. If the JBS move has you...
TSE:7181
TSE:7181Insurance

Is Japan Post Insurance’s Completed Share Buyback Shifting Its Capital Return Story (TSE:7181)?

Japan Post Insurance has now completed the share repurchase program announced on November 14, 2025, buying back 10,216,800 shares, or 2.77% of its outstanding stock, for ¥44,999.71 million by March 24, 2026. This completed buyback meaningfully reduces the share count and highlights the company’s recent focus on returning surplus capital to shareholders. We’ll now examine how the completed buyback program, and its impact on share count, may influence Japan Post Insurance’s investment...
NYSE:HE
NYSE:HEElectric Utilities

Hawaiian Electric Settlement Eases Legal Pressure But Leaves Court Risks

Hawaiian Electric Industries (NYSE:HE) has agreed to a $100 million settlement to resolve significant stockholder derivative lawsuits. The payment will be funded by insurers and also partially settles a related securities class action. The agreement is subject to final court approval, with upcoming hearings expected to clarify the remaining legal process. For shareholders watching NYSE:HE at a current share price of $14.67, this settlement addresses a key source of legal uncertainty. The...
SEHK:3320
SEHK:3320Pharmaceuticals

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal

China Resources Pharmaceutical Group (SEHK:3320) has come into focus after reporting full year 2025 results and hosting its earnings call, alongside a Board proposal to lift the final cash dividend compared with 2024. See our latest analysis for China Resources Pharmaceutical Group. The earnings release and higher proposed dividend appear to have coincided with a sharp improvement in sentiment, with a 7 day share price return of 28.67% and a 30 day share price return of 25.27% helping lift...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Is It Too Late To Consider Viavi Solutions (VIAV) After A 210% One Year Surge?

If you are wondering whether Viavi Solutions at US$34.64 is still attractively priced after a big run, the key question is what that price actually reflects about the business. The stock has delivered returns of 3.1% over the past week, 16.6% over the past month, 90.9% year to date and 209.6% over the last year, with a 225.3% return over three years and 114.0% over five years, which puts recent valuation questions front and center. Recent coverage has focused on Viavi Solutions as a...
NasdaqGM:PVLA
NasdaqGM:PVLABiotechs

Palvella Hire Highlights QTORIN Launch Plans And Deep Rare Skin Focus

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...
AIM:FRAN
AIM:FRANCommercial Services

UK Penny Stocks: 3 Picks Below £500M Market Cap

As the London markets grapple with global economic uncertainties, particularly the ripple effects of China's sluggish recovery, investors are increasingly looking for opportunities beyond the traditional blue-chip stocks. Penny stocks, though a somewhat outdated term, still represent a compelling investment area for those seeking growth potential in smaller or newer companies. When these stocks are supported by strong financials and solid fundamentals, they can offer unique opportunities for...